Crane Venture Partners is a London-based venture capital firm that focuses on early-stage technical companies, particularly in software infrastructure, data systems, and deep technology. The firm often backs highly technical founders from the earliest stages and is known for being willing to engage before broad market validation exists.

Its portfolio includes companies such as CoMind and nyra health, demonstrating interest in the intersection of AI, neurological monitoring, and brain health. Crane is not a specialist medtech fund, but it is relevant for neurotech companies with strong software, data, or intelligent systems components.

The firm’s core geographic focus is Europe, especially the UK, Germany, and Switzerland. It is most relevant for founders building neurotechnology platforms that combine technical depth with scalable software or AI layers.